These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Antimicrobial use and Pseudomonas aeruginosa susceptibility profile in a cystic fibrosis centre. Manno G; Cruciani M; Romano L; Scapolan S; Mentasti M; Lorini R; Minicucci L Int J Antimicrob Agents; 2005 Mar; 25(3):193-7. PubMed ID: 15737511 [TBL] [Abstract][Full Text] [Related]
6. Predictive factors of septic shock and mortality in neutropenic patients. Ramzi J; Mohamed Z; Yosr B; Karima K; Raihane B; Lamia A; Hela BA; Zaher B; Balkis M Hematology; 2007 Dec; 12(6):543-8. PubMed ID: 17852435 [TBL] [Abstract][Full Text] [Related]
7. Risk factors for extreme-drug resistant Pseudomonas aeruginosa infections in patients with hematologic malignancies. Liew YX; Tan TT; Lee W; Ng JL; Chia DQ; Wong GC; Kwa AL Am J Infect Control; 2013 Feb; 41(2):140-4. PubMed ID: 22795726 [TBL] [Abstract][Full Text] [Related]
8. Salvage Therapy with Ceftolozane-Tazobactam for Multidrug-Resistant Pseudomonas aeruginosa Infections. Castón JJ; De la Torre Á; Ruiz-Camps I; Sorlí ML; Torres V; Torre-Cisneros J Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 27956431 [TBL] [Abstract][Full Text] [Related]
9. A Child With Septic Shock and Purpura. Flinn A; McDermott M; Butler KM JAMA Pediatr; 2016 Apr; 170(4):391-2. PubMed ID: 27043666 [No Abstract] [Full Text] [Related]
10. [Four years of monitoring of antibiotic sensitivity rates of Pseudomonas aeruginosa and Acinetobacter baumannii strains isolated from patients in intensive care unit and inpatient clinics]. Alişkan H; Colakoğlu S; Turunç T; Demiroğlu YZ; Erdoğan F; Akin S; Arslan H Mikrobiyol Bul; 2008 Apr; 42(2):321-9. PubMed ID: 18697430 [TBL] [Abstract][Full Text] [Related]
11. Analysis of resistance, cross-resistance and antimicrobial combinations for Pseudomonas aeruginosa isolates from 1997 to 2009. Master RN; Clark RB; Karlowsky JA; Ramirez J; Bordon JM Int J Antimicrob Agents; 2011 Oct; 38(4):291-5. PubMed ID: 21737249 [TBL] [Abstract][Full Text] [Related]
12. Clinical features and risk factors for mortality in Aeromonas bacteremic adults with hematologic malignancies. Tsai MS; Kuo CY; Wang MC; Wu HC; Chien CC; Liu JW J Microbiol Immunol Infect; 2006 Apr; 39(2):150-4. PubMed ID: 16604248 [TBL] [Abstract][Full Text] [Related]
13. Clinical, microbiologic, and epidemiologic characteristics of Pseudomonas aeruginosa infections in a University Hospital, Malatya, Turkey. Yetkin G; Otlu B; Cicek A; Kuzucu C; Durmaz R Am J Infect Control; 2006 May; 34(4):188-92. PubMed ID: 16679175 [TBL] [Abstract][Full Text] [Related]
14. [Antibiotic resistance and biofilm formation in Pseudomonas aeruginosa strains isolated from patients with urinary tract infections]. Cernohorská L; Sláviková P Epidemiol Mikrobiol Imunol; 2009 Nov; 58(4):154-7. PubMed ID: 21114003 [TBL] [Abstract][Full Text] [Related]
15. [Clinical analysis of community-acquired Pseudomonas aeruginosa septic shock]. He SJ; Jin YM; Huang AR; Wang CX; Zhou AH; Wang X; Shan XO Zhonghua Er Ke Za Zhi; 2008 May; 46(5):333-9. PubMed ID: 19099748 [TBL] [Abstract][Full Text] [Related]
16. Risk factors for mortality in patients with Pseudomonas aeruginosa bacteremia: clinical impact of antimicrobial resistance on outcome. Joo EJ; Kang CI; Ha YE; Kang SJ; Park SY; Chung DR; Peck KR; Lee NY; Song JH Microb Drug Resist; 2011 Jun; 17(2):305-12. PubMed ID: 21381966 [TBL] [Abstract][Full Text] [Related]
17. [Analysis of drug resistance of Pseudomonas aeruginosa and use of antibiotics in burn wards during 6 years]. Dou Y; Zhang Q Zhonghua Shao Shang Za Zhi; 2014 Feb; 30(1):9-14. PubMed ID: 24684983 [TBL] [Abstract][Full Text] [Related]
18. The influence of metallo-beta-lactamase production on mortality in nosocomial Pseudomonas aeruginosa infections. Zavascki AP; Barth AL; Gonçalves AL; Moro AL; Fernandes JF; Martins AF; Ramos F; Goldani LZ J Antimicrob Chemother; 2006 Aug; 58(2):387-92. PubMed ID: 16751638 [TBL] [Abstract][Full Text] [Related]
19. Systemic inflammatory response syndrome in adult patients with nosocomial bloodstream infection due to Pseudomonas aeruginosa. Marra AR; Bar K; Bearman GM; Wenzel RP; Edmond MB J Infect; 2006 Jul; 53(1):30-5. PubMed ID: 16253333 [TBL] [Abstract][Full Text] [Related]
20. Antimicrobial resistance of Pseudomonas aeruginosa strains isolated from surgical infections in a 7-year period at a general hospital in Venezuela. Rodriguez CN; Rodriguez-Morales AJ; Garcia A; Pastran B; Meijomil P Surg Infect (Larchmt); 2006 Jun; 7(3):269-73. PubMed ID: 16875460 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]